Multiplication rule development- the East Holley and 39 successful experience in pharmaceutical.docVIP

 PAGE \* MERGEFORMAT 14 Multiplication rule development: the East Holley and 39 successful experience in pharmaceutical By Li Origin Many enterprises have entered a stable period in both solid industrial base, have idle funds. In order to allow enterprises to further the rapid development of enterprise decision-makers are often overwhelmed, and even weight lifting capital is flowing into an unfamiliar industry. In this way, the risks are often large and slow development. The rapid development of enterprise in order to be good at capital operation and do the multiplication. Only when a good capital operation, corporate assets can then be doubled. Core 1. To do multiplication expansion of the original industrial advantages, capital operation the best enterprise resource allocation; Two . Snowball Capital Management activated shock the fish, re-planning of the strategic restructuring of human resources is essential; Three . Corporate structure, capital operation and create opportunities for acquisition of property rights re-lay the basis for the market. Eastern bloc from 20 years ago, a small construction team, has developed into a 35 subordinate enterprises, business covering finance, trade, ports and transport industry, a large number of multinational groups, the important thing is to successfully industrial capital and financial combination of capital to carry out capital operation. 4 years of capital operation to the East Group, a rapidly expanding scale, was 15 years ago, primitive accumulation of 20 times. The Holley Group started out by cutting bamboo that can quickly take off in 1998, but also because the success of capital operation. In October 1999, Holley acquired ST Chongqing Sichuan Instrument to complete the RTO, and expanded market share in core industries. In September 2000, Holley took over ST Hengtai, access to low-cost financing channels for the new industrial system to determine carrier. The third is the acquisition of artemisinin-base